Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

International Council of Ophthalmology (ICO)/World Ophthalmology Congress

International Council of Ophthalmology (ICO)/World Ophthalmology Congress

WOC2026® Save the Date!

Join us for the World Ophthalmology Congress® (WOC2026®) of the International Council of Ophthalmology (ICO), taking place from June 26-29th 2026 in Prague, C zech Republic.

WOC2026® will  bring together the world ophthalmology community and those who work with them for a uniquely immersive learning experience designed to shape the future of sight. For more information, visit the congress website.

Further Resources

Close Popup